Amy Van Deusen

703 total citations
15 papers, 546 citations indexed

About

Amy Van Deusen is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Amy Van Deusen has authored 15 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Amy Van Deusen's work include Ion channel regulation and function (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Amy Van Deusen is often cited by papers focused on Ion channel regulation and function (4 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Amy Van Deusen collaborates with scholars based in United States, United Kingdom and Spain. Amy Van Deusen's co-authors include Edward Perez‐Reyes, Iuliia Vitko, Brian A. King, Andrew Hyland, Cheryl Higbee, Mark J. Travers, Joel P. Baumgart, Paula Q. Barrett, K. Michael Cummings and Maansi Bansal‐Travers and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Blood.

In The Last Decade

Amy Van Deusen

13 papers receiving 543 citations

Peers

Countries citing papers authored by Amy Van Deusen

Since Specialization

Citations

This map shows the geographic impact of Amy Van Deusen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Van Deusen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Van Deusen more than expected).

Fields of papers citing papers by Amy Van Deusen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Van Deusen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Van Deusen. The network helps show where Amy Van Deusen may publish in the future.

Co-authorship network of co-authors of Amy Van Deusen

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Van Deusen. A scholar is included among the top collaborators of Amy Van Deusen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Van Deusen. Amy Van Deusen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	A single-cell mass cytometry-based atlas of the developing mouse brain 2024 ·Nature Neuroscience ·Amy Van Deusen, (unknown), (unknown), (unknown), Jiachen Shi, Corey M. Williams, (unknown), (unknown), (unknown), Christopher D. Deppmann, Eli R. Zunder	3
2	Sexual dimorphism in the dorsal root ganglia of neonatal mice identified by protein expression profiling with single-cell mass cytometry 2023 ·Molecular and Cellular Neuroscience ·(unknown), Amy Van Deusen, (unknown), (unknown), (unknown), Christopher D. Deppmann, (unknown), Eli R. Zunder	0
3	A developmental atlas of somatosensory diversification and maturation in the dorsal root ganglia by single-cell mass cytometry 2022 ·Nature Neuroscience ·(unknown), Amy Van Deusen, (unknown), Corey M. Williams, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christopher D. Deppmann, Eli R. Zunder	13
4	Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia 2020 ·Figshare ·(unknown), William P. Janzen, Deborah DeRyckere, Jacqueline Norris‐Drouin, Douglas K. Graham, Amy Van Deusen, Hari S. Patel, Michael J. Miley, Mischa Machius, Debra M. Hunter, Jing Liu, Dmitri Kireev, H. Shelton Earp, Xiaodong Wang, Catherine Simpson, Victoria Korboukh, Stephen V. Frye, Gary L. Johnson, Susan Sather	0
5	Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism 2018 ·Neuropharmacology ·Sheryl S. Moy, Brian L. Teng, Viktoriya D. Nikolova, Natallia V. Riddick, Catherine Simpson, Amy Van Deusen, William P. Janzen, Maria F. Sassano, Cort A. Pedersen, Michael B. Jarstfer	19
6	The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines 2015 ·Scientific Reports ·Maurice A. Canham, Amy Van Deusen, Daniel R. Brison, Paul A. De Sousa, (unknown), Liani Devito, Zoë Hewitt, Duško Ilić, Susan J. Kimber, H. D. M. Moore, Helen C. Murray, Tilo Kunath	44
7	Quality compliance in the development of cell-based medicines in non-pharma environments 2015 ·BMC Proceedings ·Irene Oliver‐Vila, Amy Van Deusen, (unknown), Joaquim Vives	3
8	Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia 2012 ·ACS Medicinal Chemistry Letters ·Jing Liu, Chao Yang, Catherine Simpson, Deborah DeRyckere, Amy Van Deusen, Michael J. Miley, Dmitri Kireev, Jacqueline Norris‐Drouin, Susan Sather, Debra M. Hunter, Victoria Korboukh, Hari S. Patel, William P. Janzen, Mischa Machius, Gary L. Johnson, H. Shelton Earp, Douglas K. Graham, Stephen V. Frye, Xiaodong Wang	66
9	UNC569 As Novel Small Molecule Mer Receptor Tyrosine Kinase Inhibitor for Treatment of ALL 2011 ·Blood ·Sandra Christoph, Deborah DeRyckere, Susan Sather, Xiaodong Wang, Dmitri Kireev, William P. Janzen, Jing Liu, Chao Yang, Amy Van Deusen, Catherine Simpson, Jacqueline Norris‐Drouin, Stephen V. Frye, H. Shelton Earp, Gary L. Johnson, Douglas K. Graham	3
10	Secondhand smoke and particulate matter exposure in the home 2009 ·Nicotine & Tobacco Research ·Amy Van Deusen, Andrew Hyland, Mark J. Travers, Chong Wang, Cheryl Higbee, Brian A. King, T. L. Alford, K. Michael Cummings	57
11	Smoke-free homes and smoking cessation and relapse in a longitudinal population of adults 2009 ·Nicotine & Tobacco Research ·Andrew Hyland, Cheryl Higbee, Mark J. Travers, Amy Van Deusen, Maansi Bansal‐Travers, Brian A. King, K. Michael Cummings	80
12	Characterization of the Gating Brake in the I-II Loop of Cav3.2 T-type Ca2+ Channels 2008 ·Journal of Biological Chemistry ·Imilla I. Arias‐Olguín, Iuliia Vitko, Michal G. Fortuna, Joel P. Baumgart, (unknown), I.A. Shumilin, Amy Van Deusen, M. Soriano-Garcı́a, Juan Carlos Gómora, Edward Perez‐Reyes	36
13	Molecular Pharmacology of Human Cav3.2 T-Type Ca2+ Channels: Block by Antihypertensives, Antiarrhythmics, and Their Analogs 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Edward Perez‐Reyes, Amy Van Deusen, Iuliia Vitko	75
14	Validation of High Throughput Screening Assays Against Three Subtypes of Ca _v 3 T-Type Channels Using Molecular and Pharmacologic Approaches 2007 ·Assay and Drug Development Technologies ·Xinmin Xie, Amy Van Deusen, Iuliia Vitko, Daniella A. Babu, Lucinda A. Davies, Nhung Huynh, (unknown), Naibo Yang, Paula Q. Barrett, Edward Perez‐Reyes	38
15	Molecular Mechanisms of Subtype-Specific Inhibition of Neuronal T-Type Calcium Channels by Ascorbate 2007 ·Journal of Neuroscience ·Michael T. Nelson, Pavle M. Joksovic, (unknown), Ho‐Won Kang, Amy Van Deusen, Joel P. Baumgart, Laurence S. David, Terrance P. Snutch, Paula Q. Barrett, Jung‐Ha Lee, Charles F. Zorumski, Edward Perez‐Reyes, Slobodan M. Todorovic	109

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact